Issue |
J Extra Corpor Technol
Volume 36, Number 1, March 2004
|
|
---|---|---|
Page(s) | 51 - 57 | |
DOI | https://doi.org/10.1051/ject/200436151 | |
Published online | 08 August 2023 |
The In Vitro Effects of Aprotinin on Twelve Different ACT Tests
1
Department of Cardiovascular Perfusion, SUNY Upstate Medical University, Syracuse, New York
2
Department of Anesthesia, SUNY Upstate Medical University, Syracuse, New York
* Address Correspondence to: Bruce Searles, BS, CCP, Department of Cardiovascular Perfusion, SUNY Upstate Medical University, 750 East Adams Street, Syracuse, NY13210. E-mail: searlesb@upstate.edu
Aprotinin is frequently used during CPB to reduce post-operative bleeding and attenuate the inflammatory response. The level of anticoagulation in these patients is monitored by using various activated clotting time (ACT) tests, which are generally accepted as being altered by the presence of aprotinin in blood. Therefore, we have investigated the effect of aprotinin on several ACT tests using whole blood from CPB patients.With IRB approval, blood samples were collected from patients undergoing CPB before and after full heparinization (300 u/kg). Each blood sample was divided into two aliquots, and aprotinin was added to one of them to yield a final calculated concentration of 300 KIU/mL. Both aliquots were used simultaneously to perform the 12 ACT tests. A paired Student’s t-test was performed on the data. Overall, test results from 9 of 12 devices were significantly increased by aprotinin. Of these, four were increased only when the sample was heparinized, three were elevated by both heparinized and unheparinized blood, and two were elevated only when the sample was unheparinized. Each affected test responded uniquely to aprotinin, producing ACT test results ranging from 12 to 51% above nonaprotinized values. Several tests that were affected by aprotinin using heparinized blood samples were unaffected using unheparinized blood samples. These data emphasizes the unique manner in which individual ACT tests respond to aprotinized blood samples and should be considered when developing institutional policy for anticoagulation of aprotinized patients.
Key words: activated clotting time (ACT) / aprotinin / cardiopulmonary bypass (CPB) / anticoagulation
© 2004 AMSECT
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.